Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy fenjal

Start price
€41.10
01.05.24 / 50%
Target price
-
01.05.25
Performance (%)
-5.23%
Price
€38.95
21.05.24
Summary
This prediction is currently active. With a performance of -5.23%, the BUY prediction by fenjal is trending in the wrong direction. This prediction currently runs until 01.05.25. The prediction end date can be changed by fenjal at any time. fenjal has 50% into this prediction
Performance without dividends (%)
Name 1w
Bristol-Myers Squibb -5.770%
iShares Core DAX® -0.268%
iShares Nasdaq 100 1.854%
iShares Nikkei 225® 0.284%
iShares S&P 500 1.178%

According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons

Comments by fenjal for this prediction

In the thread Bristol-Myers Squibb diskutieren

Buy Bristol-Myers Squibb

Stopped prediction by fenjal for Bristol-Myers Squibb

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€68.08
03.01.23
-
03.01.24
-32.29%
28.12.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€66.35
25.03.22
-
25.04.22
6.07%
26.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.54
18.04.19
€52.32
09.06.20
30.00%
09.06.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating